![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_9564fc2936faf5c4d42425d06ed470d0.svg) | Angiotensin II | IC50 | 0.08 [1], 2.5 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_6fb2b7740ad7c1642c73ba72caccec4d.svg) | Losartan | IC50 | 19.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_a2b6ca4b5cfddd7af28200040231e2e7.svg) | Saralasin | IC50 | 0.53 [1], 1.32 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_a2b6ca4b5cfddd7af28200040231e2e7.svg) | Saralasin | Ki | 0.15 [1], 0.38 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_73e8353dd9415f963e941d5d863a68c8.svg) | Butyl N-[3-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_73e8353dd9415f963e941d5d863a68c8.svg) | Butyl N-[3-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 2.8 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_c4d4329d072cdea638d99f43afce3401.svg) | Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-propylphenyl]sulfonylcarbamate | IC50 | 4.2 [1], 6.1 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_c4d4329d072cdea638d99f43afce3401.svg) | Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-propylphenyl]sulfonylcarbamate | Ki | 1.5 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_a1d1a7314abff6ca5ee8df7d17c4ba66.svg) | PD 123319 ditrifluoroacetate | IC50 | 6.9 [1], 8.3 [2], 34.0 [3] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_9ff6a01bd51ddc6431a161043f0021f8.svg) | Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-(2-methylpropyl)phenyl]sulfonylcarbamate | IC50 | 0.7 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_9ff6a01bd51ddc6431a161043f0021f8.svg) | Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-(2-methylpropyl)phenyl]sulfonylcarbamate | Ki | 2.1 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_b7e314f9e4add33b309eaeea32feee04.svg) | (3S)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-3-(4-aminophenyl)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 0.7 [1], 0.9 [2], 1.4 [3], 2.1 [4] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_99a16b38b5df7cb8e3e4e206f20ffad2.svg) | Olodanrigan | IC50 | 0.58 [1], 0.6 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_99a16b38b5df7cb8e3e4e206f20ffad2.svg) | Olodanrigan | Ki | 39.5 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_f82f7c0d921f26658e7dd1b389389d56.svg) | Butyl N-[2-[4-[(2-ethyl-5,7-dimethylimidazo[4,5-b]pyridin-3-yl)methyl]phenyl]-4-[(3-methoxyphenyl)methyl]phenyl]sulfonylcarbamate | IC50 | 101.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_9d38dec07523278ef5ffca9eb0c779b3.svg) | Butyl N-[2-[4-(imidazol-1-ylmethyl)phenyl]-4-(2-methylpropyl)phenyl]sulfonylcarbamate | Ki | 0.6 [1], 0.7 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_06aaac731fa253276c4f13d60e300af7.svg) | Butyl N-[3-[3-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 17.8 [1], 270.0 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_220156a362868d0a368cd411c5e46918.svg) | (Sar1,Ile8)-Angiotensin II | Ki | 0.14 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_3334c5ad0ff8c1c805cbec3ed2099700.svg) | N-[4-Oxo-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]quinazolin-6-yl]-N-pentylbenzamide | IC50 | 0.7 [1], 7.0 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_0925868a9a40eafadb67638978b0f458.svg) | Butyl N-[2-[3-(imidazol-1-ylmethyl)phenyl]-4-(2-methylpropyl)phenyl]sulfonylcarbamate | Ki | 12.3 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_1be5db3868901a2107aa0a020d9c3edb.svg) | Tert-butyl N-[2-[4-[[1-[2-bromo-5-(pentanoylamino)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 0.12 [1], 3.4 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_c157854327d109406effe6af391455ac.svg) | (3S)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-4-[2-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]-2-[(4-hydroxyphenyl)methyl]-3-oxo-2,5-dihydro-1H-1,4-benzodiazepin-7-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 3.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_289bb6468f5f6ffc149467f3ea9af264.svg) | (3S)-3-Amino-4-[[(2S)-1-[[(2S)-4-[2-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-2-oxoethyl]-2-[(4-hydroxyphenyl)methyl]-3-oxo-2,5-dihydro-1H-1,4-benzodiazepin-7-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_3218ef0df658334051d7b60b6f885845.svg) | 2-Propyl-5-[(4-pyridin-2-ylpiperazin-1-yl)methyl]-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid | IC50 | 60.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_643e71f949ee1a4555bf57532192af27.svg) | Tert-butyl N-[2-[4-[[3-butyl-1-[2-chloro-5-[(2-ethoxyacetyl)amino]phenyl]-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 1.2 [1], 2.5 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_763b548108fb470a10c42aa01a718baf.svg) | Tert-butyl N-[2-[4-[[3-butyl-5-oxo-1-[5-(pentanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 0.88 [1], 3.8 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_d32b257270c50432c38a2947b00590e5.svg) | Tert-butyl N-[2-[4-[[1-(5-acetamido-2-chlorophenyl)-3-butyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]-4-propylphenyl]sulfonylcarbamate | IC50 | 0.82 [1], 12.0 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_b2a00b53c3be3ffd48fd85cfec301eaa.svg) | N-[2-[4-[[3-Butyl-5-oxo-1-[5-(propanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2-chlorobenzamide | IC50 | 1.3 [1], 3.5 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_0b3cff9201c9dfa034b624be065a3ba2.svg) | (2S,3S)-2-[[3-(Imidazol-1-ylmethyl)benzoyl]amino]-3-methylpentanoic acid;2,2,2-trifluoroacetic acid | Ki | 47000.0 [1], 110000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_c78fa8acda4e712727b6f929e1c171be.svg) | (2-Benzoylphenyl)methyl 5-ethyl-3-[[2-fluoro-4-[2-(3-methylbutoxycarbonylsulfamoyl)phenyl]phenyl]methyl]-2-propylimidazole-4-carboxylate | IC50 | 0.69 [1], 0.7 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_c88e510bbfe8e2dfb7ba27780e3d07b8.svg) | N-[2-[4-[[1-(5-Acetamido-2-chlorophenyl)-3-butyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]-4-propylphenyl]sulfonyl-2-chlorobenzamide | IC50 | 0.48 [1], 17.0 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_cdc591f729e436a2153687a8b9caa868.svg) | 1,4-Di(diphenylcarbamoyl)-(2S)-hexahydro-2-pyrazinecarboxylic acid | IC50 | 0.89 [1], 1.5 [2] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_2d2c9357fb3c1c3e7cf2db26f14cf2f7.svg) | Losartan potassium | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_545242164eb50221116b0ed84ae6f48e.svg) | Candesartan | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_5e73a1ef8d0e8c863280cb26b68ae8b5.svg) | Telmisartan | IC50 | 0.33 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_b4f76a216efed394b41035ecb49dec98.svg) | Miconazole | Ki | 7779.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_76e3c926baa83b69656964cc811e29cb.svg) | (Sar1)-Angiotensin II | Ki | 0.18 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_fdb07710278d7ccdf0d1b0106339a7b8.svg) | 4'-((2-Butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_95a2fd905b8ec00b6e3753c9f3480601.svg) | 2-Ethyl-5,7-dimethyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazo(4,5-b)pyridine | IC50 | 0.2 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_4d39830be0f5eae2ecd600ef93db8353.svg) | Potassium;2-butyl-5-methylsulfanyl-3-[[4-[2-(propylcarbamoylsulfamoyl)phenyl]phenyl]methyl]imidazole-4-carboxylate | IC50 | 920.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_c182f24056eb9eaec848b75cbbac2281.svg) | Pratosartan | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_b754a269c42e3ecd3ab65087c1e70ef1.svg) | (6S)-1-[(4-Amino-3-methylphenyl)methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid | IC50 | 66.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_ac81d37dbe35e8ea96db7ce049de2c04.svg) | 4-Ethyl-2-propyl-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylimidazole-5-carboxylic acid | IC50 | 1000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_55ea42d2e8df72f19704f5b51e68a407.svg) | 2-[4-[[2-Butyl-6-(cyclohexylcarbamoylamino)benzimidazol-1-yl]methyl]phenyl]benzoic acid | Ki | 480.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_0c080142c8a9f1144feac996e630c566.svg) | 2-[[4-[[2-Butyl-6-[methylcarbamoyl(pentyl)amino]benzimidazol-1-yl]methyl]phenyl]carbamoyl]-3,6-dichlorobenzoic acid | Ki | 730.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_1aa28ab844f3ba78680172f2f918e147.svg) | CID 5311416 | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_543f753ed466f949fa1d6d7354e80607.svg) | (2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-Amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid | IC50 | 1.74 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_8739acdbc4d03b307a99f5184ce48ed8.svg) | 2-(2,2-Diphenylacetyl)-6-methoxy-5-phenylmethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid | IC50 | 2.4 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_24cdc0838a692ac3201a6c93ac9f69d2.svg) | Nocathiacin acid | IC50 | 1120.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_57e05013148c57b46d848b2f5fe110bc.svg) | 3-[2-Butyl-4-oxo-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]quinazolin-6-yl]-1-methyl-1-propan-2-ylurea | IC50 | 4500.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_28ad5133a6994400b2723777420b818f.svg) | N-Butyloxycarbonyl-2-(4-imidazol-1-ylmethylphenyl)-4-butoxybenzenesulfonamide | Ki | 0.5 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_3fd92c249001e0afb8d96d0db7dac9eb.svg) | 2-Ethyl-7-methyl-5-(2-methylpropyl)-3-[(1S)-5-[2-(2H-tetrazol-5-yl)phenyl]-2,3-dihydro-1H-inden-1-yl]imidazo[4,5-b]pyridine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_189ff81dfd670221309359d330c192f0.svg) | Angiotensin II, ala(8)- | IC50 | 0.21 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_d1c2e3c86e46af9d30378b4703b1a4ea.svg) | Tert-butyl N-[2-[4-[[3-butyl-1-[2-chloro-5-(propanoylamino)phenyl]-5-oxo-1,2,4-triazol-4-yl]methyl]phenyl]phenyl]sulfonylcarbamate | IC50 | 5.8 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_5cf46ae1962b5eac60f3f59e43387e32.svg) | Butyl N-[2-[3-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)phenyl]sulfonylcarbamate | Ki | 8.2 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_43ec9507616a55342d5c1d6cd623804b.svg) | N-(Benzenesulfonyl)-2-[4-[[2-butyl-4-chloro-5-(hydroxymethyl)imidazol-1-yl]methyl]phenyl]benzamide | IC50 | 140.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_a54ce25be9d65d704fcb003d50ac23f5.svg) | 2-[(1S,18S,21E,28S,29S,30S)-30-[(2S,4S,5R,6S)-5-(Dimethylamino)-4-hydroxy-4,6-dimethyloxan-2-yl]oxy-9,52-dihydroxy-18-[(1R)-1-hydroxyethyl]-21-(1-methoxyethylidene)-16,19,26,31,42,46-hexaoxo-32,43,54-trioxa-3,13,23,49-tetrathia-7,17,20,27,45,51,52,55,56,57-decazadecacyclo[26.16.6.229,40.12,5.112,15.122,25.138,41.147,50.06,11.034,39]heptapentaconta-2(57),4,6,8,10,12(56),14,22(55),24,34(39),35,37,40,47,50-pentadecaen-8-yl]-N-(3-morpholin-4-ylpropyl)-1,3-thiazole-4-carboxamide | IC50 | 260.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_caf3cdd8ffc8e62c4ee8ebca92352858.svg) | 3-Butyl-1-oxido-2-[4-[2-(2H-tetrazol-5-yl)phenyl]phenoxy]quinoxalin-1-ium | Ki | 4.5 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_60e4ebe9f8f7f8eae93156c4cb56b630.svg) | (3R)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | IC50 | 0.08 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_bc38872a6361a510994e20bf6eacaf66.svg) | 2-[(1S,18S,21E,28S,29S,30S)-30-[(2S,4S,5R,6S)-5-(Dimethylamino)-4-hydroxy-4,6-dimethyloxan-2-yl]oxy-52-hydroxy-18-[(1R)-1-hydroxyethyl]-9-methoxy-21-(1-methoxyethylidene)-16,19,26,31,42,46-hexaoxo-32,43,54-trioxa-3,13,23,49-tetrathia-7,17,20,27,45,51,52,55,56,57-decazadecacyclo[26.16.6.229,40.12,5.112,15.122,25.138,41.147,50.06,11.034,39]heptapentaconta-2(57),4,6,8,10,12(56),14,22(55),24,34(39),35,37,40,47,50-pentadecaen-8-yl]-N-(3-morpholin-4-ylpropyl)-1,3-thiazole-4-carboxamide | IC50 | 5070.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_af86c93924df8db525528620ea00227b.svg) | (3S)-3-Amino-4-[[(2S)-1-[[(4R)-2-[(2S,3R)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]-4-[(4-hydroxyphenyl)methyl]-3-oxo-1,4-dihydroisoquinolin-7-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_2f5f1aa2216fe8f82b37d88a09f778c2.svg) | 2-[4-[[4-Methyl-6-(2-phenylethylcarbamoyl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid | IC50 | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_effd0b231f4b7cbd02424572c40c2dd4.svg) | 5-Methylsulfanyl-2-propyl-3-[[4-[2-(propylcarbamoylsulfamoyl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid | IC50 | 775.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_b7bc3aeb25cfedf16b05c476689b0cc9.svg) | 2-Butyl-5-methylsulfanyl-3-[[4-[2-(propylcarbamoylsulfamoyl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid | IC50 | 920.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_1e1fcc826a7e228080d20c18be6a3148.svg) | Tert-butyl N-[2-[4-[[3-butyl-5-oxo-1-[5-(propanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]phenyl]phenyl]sulfonylcarbamate | IC50 | 18.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_8849961f936ec8a17cfb2e6f43303554.svg) | Methyl 5-ethyl-3-[[2-fluoro-4-[2-(3-methylbutoxycarbonylsulfamoyl)phenyl]phenyl]methyl]-2-propylimidazole-4-carboxylate | IC50 | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_4439545f47167e25d97d47e97488cb53.svg) | 2-Cyclopropylethyl N-[2-[4-[[2-ethyl-6-[[methyl(propan-2-yl)carbamoyl]amino]-4-oxoquinazolin-3-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 6.2 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_fc38d0e6d490b2df5e5aa36fd83805f1.svg) | 3-Butyl-1-chloro-5-[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]-5,6-dihydroimidazo[1,5-a]pyridine-7-carboxylic acid | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_505d6e20cc1d5da040adeafe0433e6e5.svg) | Propan-2-yl N-[2-[4-[[3-butyl-5-oxo-1-[5-(propanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.7 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_6227ee94916c0a156d25fcbfb1bc7754.svg) | Tert-butyl N-[2-[4-[[1-[2-bromo-5-(butylcarbamoyl)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 3.7 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_310f98d39c890f685c38911f037ca90c.svg) | N-[2-[4-[[3-Butyl-1-[2-chloro-5-(propanoylamino)phenyl]-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2-chlorobenzamide | IC50 | 3.1 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_aa83cfb207ce3a954190a225cf52232c.svg) | Tert-butyl N-[2-[4-[[1-[2-bromo-5-(propanoylamino)phenyl]-3-butyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.3 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_bc2b7d82ec2a79b5ef2e7e3bf07fd6f7.svg) | Tert-butyl N-[2-[4-[[1-[5-(butylcarbamoyl)-2-(trifluoromethyl)phenyl]-5-oxo-3-propyl-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.6 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_f47e9716bc46d98e7aa94a7bb221cb31.svg) | N-[2-[4-[[1-[2-Bromo-5-(pentanoylamino)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2,5-difluorobenzamide | IC50 | 1.5 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_f283f5eb510639bc882f5ec46a093686.svg) | (3S)-3-Amino-4-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[[(1S)-1-carboxy-2-phenylethyl]carbamoyl]pyrrolidin-1-yl]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-1-oxo-4-sulfanylbutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-4-sulfanylbutan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-oxobutanoic acid | Ki | 2.1 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_7350d03818f99ec4e220832b53f10bef.svg) | Tert-butyl N-[2-[4-[[1-(5-benzamido-2-chlorophenyl)-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_b0c932d31988b87beb38881b2014ffec.svg) | Propan-2-yl N-[2-[4-[[1-[2-bromo-5-(pentanoylamino)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 1.1 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_74bdab07ef933c2c2296e1957d916d05.svg) | Tert-butyl N-[2-[4-[[3-butyl-1-[5-[(2-ethoxyacetyl)amino]-2-(trifluoromethyl)phenyl]-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.2 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_6fa54e843bb92b5205a1d4e64516116f.svg) | 2-[4-[(2-Butyl-4-oxo-5H-imidazo[4,5-c]pyridin-3-yl)methyl]phenyl]benzoic acid | IC50 | 20.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_6ca480157e332c84531cb715c81819ca.svg) | Tert-butyl N-[2-[4-[[1-[2-bromo-5-(propanoylamino)phenyl]-5-oxo-3-propyl-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 1.4 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_6168a8bdc40c024aa9c7f677bf576c24.svg) | N-[2-[4-[[1-[2-Bromo-5-(pentanoylamino)phenyl]-3-ethyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2-fluorobenzamide | IC50 | 0.64 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_a63ad64380eb963118a0a9e64342310f.svg) | N-Butyl-3-[3-butyl-4-[[4-[2-[(2-chlorobenzoyl)sulfamoyl]phenyl]-2-fluorophenyl]methyl]-5-oxo-1,2,4-triazol-1-yl]-4-chlorobenzamide | IC50 | 3.7 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_5c6ea33d3a2f230102ae46af11b5ac11.svg) | Tert-butyl N-[2-[4-[[1-[5-benzamido-2-(trifluoromethyl)phenyl]-3-butyl-5-oxo-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 6.3 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_ad7da83e878d939232f96a7fae37edbd.svg) | N-Iso-Butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide | Ki | 37.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_36f35a8d2072bde7f46ca8bf9c1f39f6.svg) | Tert-butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 63.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_e31c19fd6fca9f097534df4b445404eb.svg) | N-Butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-butylthiophene-2-sulfonamide | Ki | 5.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_c9a8a0413a5b9d3360f45217c2d9966c.svg) | Ethyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 10.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_b8e58da18fcc1bc7daaf24dcc6a61176.svg) | N-Iso-propyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide | Ki | 75.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_89aaff1d09a535b04c98ba168af85abe.svg) | 2-Butoxy-N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylacetamide | Ki | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_938bcd157c1c49c4a90382a8d93565b3.svg) | N-Butylsulfonyl-3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-carboxamide | Ki | 79.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_a83db9f632b0335103551a8fc3a97a51.svg) | Butyl N-[3-[4-[(2-ethylbenzimidazol-1-yl)methyl]phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate | Ki | 3.2 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_3becb32f6689c4fedf580d6370d06fc5.svg) | N-Butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-(2-Methoxy-ethyl)thiophene-2-sulfonamide | Ki | 86.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_084fcde6b27854fc9db482b1b8dbaea5.svg) | 1-Butyl-3-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylurea | Ki | 13.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_92395ff587e139ccd44952cc356c3459.svg) | N-[2-[4-[[3-Butyl-5-oxo-1-[5-(propanoylamino)-2-(trifluoromethyl)phenyl]-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonyl-2-fluorobenzamide | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_1e56994d69f7d004a202b501958550c0.svg) | Tert-butyl N-[2-[4-[[1-[2-bromo-5-(pentanoylamino)phenyl]-5-oxo-3-propyl-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 2.2 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_0d1606a4de8b9d0ae6cfc2a1ecf2490f.svg) | Tert-butyl N-[2-[4-[[1-[5-benzamido-2-(trifluoromethyl)phenyl]-5-oxo-3-propyl-1,2,4-triazol-4-yl]methyl]-3-fluorophenyl]phenyl]sulfonylcarbamate | IC50 | 5.3 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_4f86496d0b641b408cfca664c53e2db7.svg) | 4-Bromo-N-butyl-3-[4-[[4-[2-[(2,5-dichlorobenzoyl)sulfamoyl]phenyl]-2-fluorophenyl]methyl]-5-oxo-3-propyl-1,2,4-triazol-1-yl]benzamide | IC50 | 2.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_aa28abd508e4e5426981fd2cb8476f6a.svg) | l-Histidyl-l-prolyl-l-phenylalanine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/angiotensin-ii-type-2-at-2-receptor_ec74d85a3b6a7e874b709a599bef9a06.svg) | N-Butyloxycarbonyl-2-(4-imidazol-1-ylmethylphenyl)-4-butylbenzenesulfonamide | Ki | 5.0 [1] |